SAMHD1 Silencing Cooperates with Radiotherapy to Enhance Anti-tumor Immunity Through IFI16-STING Pathway in Lung Adenocarcinoma
Overview
General Medicine
Authors
Affiliations
Background: Sterile alpha motif domain and histidine-aspartate domain-containing protein 1 (SAMHD1) is a DNA end resection factor, which is involved in DNA damage repair and innate immunity. However, the role of SAMHD1 in anti-tumor immunity is still unknown. This study investigated the effects of SAMHD1 on stimulator of interferon genes (STING)-type I interferon (IFN) pathway and radiation-induced immune responses.
Methods: The roles of SAMHD1 in the activation of cytosolic DNA sensing STING pathway in lung adenocarcinoma (LUAD) cells were investigated with flow cytometry, immunofluorescence, immunoblotting and qPCR. The combined effects of SAMHD1 silencing and radiation on tumor cell growth and STING pathway activation were also evaluated with colony formation and CCK8 assay. The Lewis lung cancer mouse model was used to evaluate the combined efficiency of SAMHD1 silencing and radiotherapy in vivo. Macrophage M1 polarization and cytotoxic T cell infiltration were evaluated with flow cytometry.
Results: The single-stranded DNA (ssDNA) accumulated in the cytosol of SAMHD1-deficient lung adenocarcinoma (LUAD) cells, accompanied by upregulated DNA sensor IFN-γ-inducible protein 16 (IFI16) and activated STING pathway. The translocation of IFI16 from nucleus to cytosol was detected in SAMHD1-deficient cells. IFI16 and STING were acquired in the activation of STING-IFN-I pathway in SAMHD1-deficient cells. SAMHD1 silencing in LUAD cells promoted macrophage M1 polarization in vitro. SAMHD1 silencing synergized with radiation to activate ssDNA-STING-IFN-I pathway, inhibit proliferation, promote apoptosis and regulate cell cycle. SAMHD1 silencing cooperated with radiotherapy to inhibit tumor growth and increase CD86MHC-II M1 proportion and CD8 T cell infiltration in vivo.
Conclusions: SAMHD1 deficiency induced IFN-I production through cytosolic IFI16-STING pathway in LUAD cells. Moreover, SAMHD1 downregulation and radiation cooperated to inhibit tumor growth and enhance anti-tumor immune responses through macrophage M1 polarization and CD8 T cell infiltration. Combination of SAMHD1 inhibition and radiotherapy may be a potentially therapeutic strategy for LUAD patients.
SAMHD1 enhances HIV-1-induced apoptosis in monocytic cells via the mitochondrial pathway.
Yang H, Cheung P, Wu L bioRxiv. 2025; .
PMID: 39829911 PMC: 11741301. DOI: 10.1101/2025.01.08.632057.
Ampelopsis japonica enhances the effect of radiotherapy in non-small cell lung cancer.
Liu Z, Cui P, Wu Q, Ji X Strahlenther Onkol. 2024; .
PMID: 39630250 DOI: 10.1007/s00066-024-02322-7.
Kobayashi Y, Bustos M, Hayashi Y, Yu Q, Hoon D J Immunother Cancer. 2024; 12(10).
PMID: 39424359 PMC: 11492949. DOI: 10.1136/jitc-2024-009590.
Role of STING in the treatment of non-small cell lung cancer.
Tang W, Zhou W, Ji M, Yang X Cell Commun Signal. 2024; 22(1):202.
PMID: 38566036 PMC: 10986073. DOI: 10.1186/s12964-024-01586-x.
Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.
Zhang J, Yu S, Peng Q, Wang P, Fang L Cancer Biol Med. 2024; 21(1).
PMID: 38172538 PMC: 10875285. DOI: 10.20892/j.issn.2095-3941.2023.0440.